Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 23, 20 December 2023
* Author to whom correspondence should be addressed.
Gene editing is a technique in genetic engineering that aims to change specific genes in the genome of a certain organism mainly by modifying specific genes, such as by adding or deleting them. It has a profound meaning in the treatment of human genetic ailments and in the modification of diseased genes in plants and animals, and is also one of the hottest research areas in the life sciences in recent years. This paper focuses on the development of CRISPR/Cas9-based single-base editing technologies after 2019, especially after the advent of lead editing. Researchers in various countries have applied it to rice and mice for experiments to ameliorate the accuracy of single-base editing and decrease off-target effects, and have tested the accuracy and conversion rate of prime editing (PE) by whole-genome sequencing and other methods, and have continued to innovate on this basis to pursue more efficient editing results. This paper summarizes the problems that still need to be solved for PE, so that it can serve as a reference in the future research process and better develop prime editor and gene editing.
CRISPR/Cas9, single-base editing, prime editing, CBE, ABE
1. Komor, A., Kim, Y., Packer, M. et al. “Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.” Nature 533, 420-44 (2016).
2. Gaudelli, N., Komor, A., Rees, H. et al. “Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.” Nature 551, 464–471 (2017).
3. Zuo, E., Sun, Y., Wei, W. et al. “Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos.” Science 364(6437), 289-292 (2019).
4. Jin, S., Zong,Y., Gao,Q. et al. “Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice.” Science 364(6437), 292-295 (2019).
5. Chen, Y., Chen, YX., Ping, Y. “Application of base editing systems in the treatment of genetic diseases.” Journal of Pharmaceutical Sciences, 55(07):1562-1572 (2020).
6. Landrum, J., Lee, M., Benson, M. et al. “ClinVar: public archive of interpretations of clinically relevant variants.” Nucleic Acids Res 44(D1): D862-8 (2016).
7. Anzalone, A.V., Randolph, P.B., Davis, J.R. et al. “Search-and-replace genome editing without double-strand breaks or donor DNA.” Nature 576, 149–157 (2019).
8. Chung J., et al. “Molecular changes in appearance of a cancer cell among normal HEK293T cells.” Journal of Bioscience and Bioengineering 123, 3 (2017).
9. Doman, J.L., Raguram, A., Newby, G.A. et al. “Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors.” Nat Biotechnol 38, 620–628 (2020).
10. Zuo, E., Sun, Y., Yuan, T. et al. “A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects.” Nature Methods, 17(6), 600-604 (2020).
11. Zuo, E., Sun, Y., Wei, W. et al. “GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos.” Nat Protoc 15, 3009–3029 (2020).
12. Jin, S., Lin, Q., Luo, Y. et al. “Genome-wide specificity of prime editors in plants.” Nat Biotechnol 39, 1292–1299 (2021).
13. Chen, P., Hussmann, J. et al. “Enhanced prime editing systems by manipulating cellular determinants of editing outcomes.” Cell. 184(22):5635-5652.e29 (2021).
14. Jiang, T., Zhang, XO., Weng, Z. et al. “Deletion and replacement of long genomic sequences using prime editing.” Nat Biotechnol 40, 227–234 (2022).
15. Choi, J., Chen, W., Suiter, C.C. et al. “Precise genomic deletions using paired prime editing.” Nat Biotechnol 40, 218–226 (2022).
16. Davis, J.R., Banskota, S., Levy, J.M. et al. “Efficient prime editing in mouse brain, liver and heart with dual AAVs.” Nat Biotechnol (2023).
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).